Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SINOVAC BIOTECH LTD.

(SVA)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
Business Summary
Logo Sinovac Biotech Ltd.
Sinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, RabEnd, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine, Rubella Vaccine, Varicella Vaccine and Sabin Inactivated Polio Vaccine.

Number of employees : 1 959 people.
Sales per Business
2020
Biotechnology510.62100%
USD in Million
Sales per region
20192020Delta
China227.1192.3%365.6271.6% +60.99%
International18.947.7%145.0028.4% +665.6%
USD in Million
Managers
Name Title Age Since
Wei Dong Yin, Dr. Chairman, President, CEO, Secretary & MD 56 2003
Nan Wang CFO & Vice President-Business Development 53 2013
Qiang Gao Chief Operating Officer & Vice President 43 2020
Yuk Lam Lo Independent Director 71 2006
Jian Li Independent Director 51 2011
Meng Mei Independent Director 65 2012
Simon J. Anderson Independent Director 58 2004
Shan Fu Independent Director 53 2018
Helen G. Yang Investor Relations Contact - -
Xiao Mei Yin Vice President-Sales & Marketing 56 2017
Members of the board
Name Title Age Since
Wei Dong Yin, Dr. Chairman, President, CEO, Secretary & MD 56 2003
Yuk Lam Lo Independent Director 71 2006
Jian Li Independent Director 51 2011
Meng Mei Independent Director 65 2012
Simon J. Anderson Independent Director 58 2004
Shan Fu Independent Director 53 2018
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 71,517,402 23,961,767 33.5% 0 0.0% 33.5%
Stock B 0 14,630,813 0 0.0% 0 0.0%
Shareholders
NameEquities%
1Globe Capital LLC 18,515,315 26.0%
SAIF Advisors Ltd. 10,780,820 15.2%
Wei Dong Yin 6,359,500 8.94%
CDH Investment Advisory Pte. Ltd. 6,000,000 8.43%
Vivo Capital LLC 5,900,000 8.29%
Sansar Capital Management LLC 2,953,503 4.15%
OrbiMed Advisors Private Equity 2,839,500 3.99%
Martin Currie Investment Management Ltd. 2,025,666 2.85%
Manning & Napier Advisors LLC 1,435,270 2.02%
Davis Selected Advisers LP 1,250,546 1.76%
Company contact information
Sinovac Biotech Ltd.
Zhongguancun Science & Technology
No. 15 Zhi Tong Road
Changping District
Beijing 102200

Phone : +86.10.5693.1800
Fax : +86.10.5693.1800
Web : http://www.sinovacbio.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Sinovac Biotech Ltd.